Since studies in CLL suggest that the MDM2 SNP309 GG genotype associate with low miR34A expression and poor prognosis, we investigated the role of this SNP in a subset (120) of these primary DLBCLs, but observed no prognostic impact (see Supplemental Material). This evidence concerns the gene MDM2 and B-cell chronic lymphocytic leukemia.